Human leukocyte antigen-DR and ABO mismatch are associated with accelerated homograft valve failure in children: implications for therapeutic interventions.

Human leukocyte antigen-DR and ABO mismatch are associated with accelerated homograft valve failure in children: implications for therapeutic interventions.

Item
http://www.wikidata.org/entity/Q45163955
Bioengineered human and allogeneic pulmonary valve conduits chronically implanted orthotopically in baboons: hemodynamic performance and immunologic consequencesRegenerative potential of low-concentration SDS-decellularized porcine aortic valved conduits in vivo.Tolerance to incompatible ABO blood group antigens is not observed following homograft implantation.Factors influencing late allograft valve failure.Immune response to allograft implantation in children with congenital heart defects.Homografts in aortic position: does blood group incompatibility have an impact on patient outcomes?Decellularization of human donor aortic and pulmonary valved conduits using low concentration sodium dodecyl sulfate.Mid- to long-term outcomes of cardiovascular tissue replacements utilizing homografts harvested and stored at Japanese institutional tissue banks.Development and characterisation of a large diameter decellularised vascular allograft.Decellularized Allografts for Right Ventricular Outflow Tract Reconstruction in Children.Pulse Duplicator Hydrodynamic Testing of Bioengineered Biological Heart Valves.
P2860

Human leukocyte antigen-DR and ABO mismatch are associated with accelerated homograft valve failure in children: implications for therapeutic interventions.

Item
http://www.wikidata.org/entity/Q45163955
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Human leukocyte antigen-DR and ...... for therapeutic interventions.
@en
Human leukocyte antigen-DR and ...... for therapeutic interventions.
@nl
type
label
Human leukocyte antigen-DR and ...... for therapeutic interventions.
@en
Human leukocyte antigen-DR and ...... for therapeutic interventions.
@nl
prefLabel
Human leukocyte antigen-DR and ...... for therapeutic interventions.
@en
Human leukocyte antigen-DR and ...... for therapeutic interventions.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P356
P1433
P1476
Human leukocyte antigen-DR and ...... for therapeutic interventions.
@en
P2093
P304
P31
P356
10.1016/S0022-5223(03)00210-1
P407
P433
P478
P577
P5875
P698